SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following news of Elon Musk's $1 billion stock purchase, signaling confidence in the company's future and sparking a rally among investors. The community is debating whether this is a long-term bullish signal or a short-term pump, with some focusing on the company's potential in robotics and AI, while others point to ongoing concerns about valuation and market competition.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid retail interest possibly sparked by a congressional disclosure of stock purchases and speculation around future government contracts, drawing comparisons to Palantir ($PLTR). Bullish investors are actively analyzing chart patterns, anticipating a short squeeze, and expressing optimism about the company's AI-driven solutions within the growing AI for defense and security sector.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending as its community rallies around its real-world brand-building efforts and growing holder base, highlighting a new energy drink flavor and upcoming meet-up. Community members express strong conviction in the project's long-term potential, emphasizing its unique approach and active development. Despite market fluctuations, the community remains focused on organic growth and strategic initiatives.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle ($ORCL) is trending amid speculation around its involvement in a potential TikTok deal, with community members discussing the likelihood and potential impact of such an acquisition. Some traders believe positive news could send the stock soaring, while others express skepticism about the deal's value and sustainability, pointing to concerns about a possible "pump and dump" scenario. The stock's recent volatility, following a significant post-earnings surge, is also fueling debate about its near-term direction.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors anticipate a potential rate cut decision from the Federal Reserve, while some traders express concerns about overvaluation and a possible "sell the news" event. Community chatter revolves around the sustainability of the current rally, with discussions about market mechanics, potential pullbacks, and the impact of the Fed's actions, as well as signs that insiders are selling.

Slopana

$SLOPANA.X is gaining traction as the self-proclaimed 'king of digital slop,' capitalizing on the meme coin frenzy within the Solana ecosystem. Community members highlight its strong community, CTO leadership and are actively encouraging others to join before a potential surge, referencing its availability on Phantom Wallet.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as the "Wolfpack" community rallies around the token, fueled by comparisons to past meme coin successes and a narrative of reclaiming lost glory. Discussions highlight a strong community, dedicated developer actions, and anticipation for future growth and potential listings. Despite some skepticism, the prevailing sentiment is bullish, with community members emphasizing the token's potential and encouraging accumulation.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics ($GLUE) is trending due to a $5.7 billion deal with Novartis for immune-mediated disease drugs, sparking excitement among investors. The community is discussing the potential for a short squeeze and comparing it to other recent high-flying stocks. Bullish sentiment is fueled by the significant upfront payment and future milestone potential, although some traders remain cautious.

Welcome to Auklora  Dive into the ultimate crypto penguin metaverse! Play, earn, and explore in our cozy Solana-powered world.  Earn $AUK Tokens  Collect coins while playing Auklora and convert them to $AUK tokens. Use our calculator to see how many tokens you can earn!  Create your unique penguin avatar with hundreds of clothing items, accessories, and special effects. Stand out in the crowd!  Explore the beautiful world of Auklora through these stunning screenshots from our community

Auklora

Auklora ($AUK.X) is trending as the community highlights its potential as a "Phantom gem," focusing on accumulation. The project's association with the Phantom chain is sparking interest and driving conversation among investors.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending following news that its Black Widow drone system has been approved for NATO's procurement catalog, potentially opening doors to significant sales within member nations. While some express concerns over potential dilution and past stock performance, the community is largely optimistic, viewing this as a major catalyst for future revenue growth and market expansion, especially with the development of USV (Unmanned Surface Vessels) capabilities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains?

CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

InspireMD Launches CGuard Prime Carotid Stent System in the U.S.

NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.

Shares of InspireMD, Inc. (NSPR) dipped nearly 1% on Friday morning after it <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.inspiremd.com/en/press-center/inspiremd-reports-first-quarter-2025-financial-results/">reported</a> a wider-than-expected first quarter (Q1) loss.The company’s revenue for the quarter increased 1.2% year-on-year (YoY) to $1.52 million, above an analyst estimate of $1.45 billion, as per Finchat data.The marginal increase in revenue was driven by the continued adoption of the company’s CGuard technology in existing markets. It was offset by the impact of foreign exchange and distributors managing inventory levels in anticipation of an approval for CGuard Prime in Europe.InspireMD’s CGuard Prime carotid stent system is used to treat carotid artery disease and prevent stroke.Net loss per share came in at $0.22, compared to a net loss of $0.21 per share for the same period in 2024, but wider than an estimated loss of $0.2.The company said that it is continuing to engage with the U.S. Food and Drug Administration (FDA) regarding the application it submitted to obtain marketing approval for the CGuard Prime carotid stent system.The company also expressed optimism about approval for the system in the third quarter of 2025.CEO Marvin Slosman said that the firm’s commercial team is ready to execute at scale upon receiving FDA approval for the technology.“We continue to work interactively with the FDA and are optimistic for an anticipated approval of CGuard Prime in the third quarter of 2025. Despite dynamics within the agency and the timing of our audit in February, we are confident the remaining items will be successfully completed,” he said.On Stocktwits, retail sentiment around InspireMD stayed unmoved within the ‘bullish’ territory over the past 24 hours while message volume remained at ‘high’ levels.&nbsp; &nbsp;<figure class="image"><img style="aspect-ratio:629/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_09_at_11_03_25_AM_png_e35692eebb.webp" alt="NSPR's Sentiment Meter and Message Volume as of 11 a.m. ET on May 9, 2025 | Source: Stocktwits" width="629" height="62"><figcaption>NSPR's Sentiment Meter and Message Volume as of 11 a.m. ET on May 9, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/NSPR">NSPR stock</a> is down by about 3% this year but up by nearly 17% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ocugen-reports-lower-than-expected-q1-loss/chiWHRQRblX">Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart is opened in a trading platform on a smartphone. Photo: Silas Stein/dpa (Photo by Silas Stein/picture alliance via Getty Images)

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic

The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets.

Equity

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today...

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today...

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

- Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 - - Announced positive 30-day data from the Company's ongoing U.S. Investigational Device...

Avance de ganancias de InspireMD

El mi rcoles, 06 de marzo, InspireMD (NASDAQ:NSPR) publicar su ltimo informe de ganancias. Analiza la noticia con ayuda de Benzinga.
Ingresos netos, ganancias y beneficios por acci n
Las ganancias...

InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th

-Conference call and webcast to be held at 8:30 a.m. EST- TEL AVIV, Israel and MIAMI, Feb. 28, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard...

InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard  Neuroprotection System

Development of SwitchGuard consistent with Company's mission to uniquely support both Carotid Artery Stenting (CAS) and Transcarotid Artery Revascularization (TCAR) procedures with best-in-class...

InspireMD Receives CE Mark Recertification Under EU's New Medical Device Regulation (MDR) Regulatory Framework

TEL AVIV, Israel and MIAMI, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Carotid Stent System (EPS) for the prevention of stroke...

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

InspireMD Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

NSPR
InspireMD Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NSPR News

NSPR InspireMD Inc